Malin Deon | Investor Relations |
Rich Murray | Chief Executive Officer & President |
Dmitri Wiederschain | Chief Scientific Officer |
Beth Trehu | Chief Medical Officer |
Kim Drapkin | Chief Financial Officer |
Ryan Deschner | Raymond James |
Swayampakula Ramakanth | H.C. Wainwright |
Colleen Kusy | Baird |
Boris Peaker | Cowen |
Nick Abbott | Wells Fargo Securities |
Zegbeh Jallah | ROTH Capital |
Ted Tenthoff | Piper Sandler |
Good morning, ladies and gentlemen and welcome to the Jounce Therapeutics First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder this conference call is being recorded at the company's request. I will now turn the call over to your host Malin Deon, with Jounce Therapeutics.